Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

BACKGROUND: Single agent immune checkpoint inhibitors (ICIs) improve survival outcomes compared to chemotherapy for advanced non‐small cell lung cancer (NSCLC), but treatment efficacy widely varies. The combination of ICIs with chemotherapy has shown promising efficacy over chemotherapy alone; howev...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Thorac Cancer
Huvudupphovsmän: Kuo, Chih‐Hsi Scott, Wang, Chin‐Chou, Huang, Yu‐Chen, Pavlidis, Stelios, Liu, Chien‐Ying, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Wang, Chih‐Liang, Guo, Yi‐Ke, Yang, Cheng‐Ta
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons Australia, Ltd 2019
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501017/
https://ncbi.nlm.nih.gov/pubmed/30950239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13057
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk